ESC Congress 2026 Abstract
LDL-C target achievement does not equal risk resolution after ACS: residual atherogenic and inflammatory burden despite maximal oral triple lipid therapy
Cohort study of 426 peopleInterventions
Papers on ApoB discordance
6 papers3 new in 30 days